Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 306 recruiting now early-phase tilt #3 of 28,963 conditions

Obesity: early-phase trial registry

306 of 1,057 indexed Obesity trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #3 of 28,963 conditions by registered trial count.

1,057 US clinical trials · 306 currently recruiting · #3 of 28,963 conditions by registered trial count

Obesity: 1,057 US clinical trials tracked, 306 recruiting.

Obesity is the subject of 1,057 registered US clinical trials on ClinicalTrials.gov, 306 of them currently open to new participants. 107 are in Phase 3-4 (later-stage) and 196 in Phase 1-2 (earlier-stage). The most active sponsor is Eli Lilly and Company, running 48 of these trials.

Open enrollment, early-phase tilt

Obesity has 1,057 registered US clinical trials, 306 of them open to new participants right now, about 29% of the total.

306
recruiting participants now
29%
of trials open to enrollment
107
in Phase 3-4 (later-stage)
48
top sponsor: Eli Lilly and Company

Corpus placement: #3 of 28,963 conditions by registered trial count on ClinicalTrials.gov-derived indexes. Registry reference only, not medical advice.

Key findings

What ClinicalTrials.gov does not surface for Obesity on its own pages , computed from the registry mirror as of 2026-07-11. Each line carries its own denominator so it can be quoted as it stands.

  1. Obesity is recruiting below its size-band peers.

    306 of 1,057 indexed trials (28.9%) are open to enrollment, against a 37.2% average across 135 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Obesity trials is spread across many organizations.

    Eli Lilly and Company accounts for 48 of 1,057 trials (4.5%). 314 distinct sponsors appear on at least one study for this condition label.

  3. Typical Obesity enrolment sits around 90 participants.

    Median target enrolment is 90 among the 1,054 trials that report a genuine target (sentinel values excluded). 555 of those (52.7%) plan for fewer than 100 participants.

  4. Obesity research is mostly interventional.

    894 interventional and 163 observational studies make up this index (84.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 195Phase 2101Phase 369Phase 438

Open and recent trials

1,057 total, page 15 of 22

COMPLETED NA 101 participants

Reinforcement of Surgical Staple Lines Using Peri-Strips Dry (PSD) With Veritas Collagen Matrix

Baxter Healthcare Corporation

NCT00566943

COMPLETED Phase 4 101 participants

Pain Control in Bariatric Patients: EXPAREL(R) vs. the On-Q(R) Pain Ball

Pacira Pharmaceuticals

NCT02142829

COMPLETED NA 100 participants

Enhanced Internet Behavior Therapy for Treating Obesity

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NCT00212238

COMPLETED NA 100 participants

Long Term Free Living Study With Modified Foods and Type 2 Diabetics

Johns Hopkins Bloomberg School of Public Health

NCT00198913

COMPLETED NA 100 participants

Exercise Intolerance in Elderly Patients With Diastolic Heart Failure

Wake Forest University

NCT00959660

COMPLETED 100 participants

Obesity in G60 Trauma Patients / Obesity in G60 Trauma Patients

Methodist Health System

NCT04640701

COMPLETED 100 participants

Effects of Advertising on Young Children's Perception of Taste

Stanford University

NCT00185536

COMPLETED NA 100 participants

Predicting Adherence to a Heart-Healthy Diet in Lean and Obese Individuals

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NCT01862796

COMPLETED 100 participants

The Effects of Overfeeding on Obesity-Prone (OP) and Obesity-Resistant (OR) Women

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NCT00072917

COMPLETED Phase 1 100 participants

A Research Study on How a Dose of NNC0662-0419 Works in Japanese, Chinese and Non-Asian Participants Living With Overweight or Obesity

Novo Nordisk A/S

NCT07101783

COMPLETED NA 99 participants

PATH to Health: An Exploration of Digital Behavioral Weight Loss Approaches

University of North Carolina, Chapel Hill

NCT05929469

COMPLETED NA 99 participants

Balanced (Egg) Protein During Obesity Reduction: Differential Responses of Insulin Resistance by Race

Duke University

NCT03771261

COMPLETED 97 participants

The Collateral Impact of Bariatric Surgery on Families

Geisinger Clinic

NCT02021630

COMPLETED NA 97 participants

Lifestyle Changes Through Exercise and Nutrition

Pennington Biomedical Research Center

NCT02863887

COMPLETED Phase 1 96 participants

Reducing Antipsychotic-Induced Weight Gain in Children With Metformin

Nationwide Children's Hospital

NCT01231074

COMPLETED Phase 1 96 participants

A Study of LY3841136 in Overweight and Obese Participants

Eli Lilly and Company

NCT06345066

COMPLETED NA 95 participants

Assisted Exercise in Obese Endometrial Cancer Patients

Case Comprehensive Cancer Center

NCT01870947

COMPLETED NA 94 participants

Eating Behaviors Among Weight-Discordant Siblings

University of Pennsylvania

NCT01598389

COMPLETED Phase 1 93 participants

A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses and Multiple Doses of NNC0165-1562 in Overweight to Obese But Otherwise Healthy Subjects

Novo Nordisk A/S

NCT02568306

COMPLETED 93 participants

The Sweet PEA Study: Effects of Diet During Pregnancy on Infant Growth and Development.

University of Southern California

NCT04674033

COMPLETED NA 93 participants

Examination of a Treatment Program for Overweight Children, Adolescents, and Their Families

University of Kansas

NCT00365807

COMPLETED NA 92 participants

Puberty Related Intervention to Improve Metabolic Outcomes (The PRIMO Study)

University of Alabama at Birmingham

NCT01410643

COMPLETED NA 92 participants

Weight Watchers Online 2015

The Miriam Hospital

NCT02417220

COMPLETED NA 90 participants

"Reversibility of Cardiovascular Injury With CPAP Use: Mechanisms Involved"

University of Wisconsin, Madison

NCT01317329

COMPLETED 90 participants

Taste Perception and Chronic Disease Risk

Tufts University

NCT01023906

COMPLETED NA 89 participants

Weight Loss in Adults Over 50 with Obesity

University of Alabama at Birmingham

NCT04014296

COMPLETED NA 88 participants

Exercise Genes: Genomic Association With Exercise Reinforcement

USDA Grand Forks Human Nutrition Research Center

NCT02416882

COMPLETED NA 88 participants

Surgery or Lifestyle With Intensive Medical Management in the Treatment of Type 2 Diabetes

Joslin Diabetes Center

NCT01073020

COMPLETED NA 85 participants

"Generation Fit and Exerlearning With In the Groove"

MaineHealth

NCT00424918

COMPLETED Phase 1 84 participants

A School Nurse-Delivered Intervention for Overweight and At Risk Adolescents

University of Massachusetts, Worcester

NCT00682188

COMPLETED Phase 1 84 participants

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Food Effect of NO-13065 in Healthy and Obese Adult Subjects

Otsuka Pharmaceutical Factory

NCT04838639

COMPLETED NA 83 participants

Families Becoming Healthy Together

The University of Tennessee, Knoxville

NCT04027426

COMPLETED NA 82 participants

Study of Coffee Mannooligosaccharides for Weight Management

Mondelēz International

NCT00932750

COMPLETED Phase 1 82 participants

A Study to Learn How the Study Medicine Danuglipron is Taken Up Into the Blood and If Danuglipron Changes How the Body Processes Other Study Medicines (Atorvastatin and Rosuvastatin) in Healthy Adults Who Are Overweight or Obese

Pfizer

NCT06567327

COMPLETED NA 81 participants

An Enhanced Protein (Dairy) Weight Loss Intervention for Dynapenic Obesity: Impact on Muscle Quality and Composition

Duke University

NCT02437643

COMPLETED NA 80 participants

Efficacy of Parent-Child Dieting Plans Incorporating Medifast Meal Replacements for Weight Loss

Johns Hopkins Bloomberg School of Public Health

NCT00198744

COMPLETED NA 80 participants

Improving Metabolic Health in Patients With Diastolic Dysfunction

University of Texas Southwestern Medical Center

NCT03448185

COMPLETED NA 80 participants

Evaluation of a Health at Every Size vs a Behavioral Weight Loss Approach for Obese Women

The Reading Hospital and Medical Center

NCT00769717

COMPLETED NA 80 participants

Applying Social Comparison Theory to Behavioral Weight Loss: Does Modifying Group Membership Improve Outcome?

The Miriam Hospital

NCT00716027

COMPLETED NA 79 participants

A Weight Loss Trial for Emotional Eating

Temple University

NCT02055391

COMPLETED NA 79 participants

Insulin and the Polycystic Ovary Syndrome--Weight Reduction Study

Virginia Commonwealth University

NCT00436865

COMPLETED NA 79 participants

Effect of 4-week Dihydrocapsiate Ingestion on Resting Metabolic Rate

Pennington Biomedical Research Center

NCT00999297

COMPLETED NA 77 participants

In-home Obesity Prevention to Reach Low-income Infants

University of Southern California

NCT03529695

COMPLETED Phase 3 77 participants

An Interactive Web-based Intervention to Achieve Healthy Weight in Young Children

University of Wisconsin, Madison

NCT01552642

COMPLETED NA 77 participants

Phone Coaching for Weight Loss Maintenance

The Miriam Hospital

NCT04293055

COMPLETED NA 76 participants

Physical Activity Referrals to the Community

University of California, Berkeley

NCT02044744

COMPLETED NA 76 participants

Gamification and Energetic Behavior Changes

Children's Hospital of Philadelphia

NCT03050840

COMPLETED NA 75 participants

Nutrition Outreach and Understanding: Research In Serving Hearts Through Healthy Eating And Tailored Support

Amanda Shallcross

NCT06460272

COMPLETED 75 participants

The Optimum Time for Preoxygenation Based on Body Mass Index

Cedars-Sinai Medical Center

NCT01114932

COMPLETED NA 75 participants

Feasibility of Integrating Indirect Calorimetry (IC) Technology in Primary Care

Colorado Center for Chronic Care Innovations

NCT00750022

← Previous Page 15 of 22 Next →

Phase Distribution

PhaseTrial count
Phase 1 95
Phase 2 101
Phase 3 69
Phase 4 38

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What is open for Obesity right now

306 recruiting of 1,057 indexed (29% open).

Phase mix: 107 late (III/IV) vs 196 early (I/II) (early-phase heavy).

Top sponsor: Eli Lilly and Company (48 trials), 9 others listed. 50 shown below, recruiting first. #3 of 28,963 conditions by registered trial count.

How open-enrollment share is computed

Open share is recruiting_count divided by trial_count for this condition label in the public registry export. Status can change between pulls; treat the figure as a snapshot of research attention, not treatment availability.

Frequently Asked Questions

How many clinical trials are there for Obesity?

PlainTrial tracks 1,057 US clinical trials for Obesity, of which 306 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for Obesity?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.